Viewing Study NCT00002903

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2026-02-07 @ 3:43 PM
Study NCT ID: NCT00002903
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extragonadal Germ Cell Tumor View
None Ovarian Cancer View
None Testicular Germ Cell Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent malignant testicular germ cell tumor View
None testicular seminoma View
None recurrent ovarian germ cell tumor View
None extragonadal germ cell tumor View